Table of Contents
International Journal of Molecular Imaging
Volume 2015, Article ID 469047, 10 pages
http://dx.doi.org/10.1155/2015/469047
Research Article

Comparison of Folate Receptor Targeted Optical Contrast Agents for Intraoperative Molecular Imaging

1Division of Thoracic Surgery, Department of Surgery, University of Pennsylvania and Philadelphia VA Medical Center, Philadelphia, PA 19104, USA
2On Target Laboratories, Inc., West Lafayette, IN 47906, USA
3Departments of Biomedical Engineering and Chemistry, Emory University, Atlanta, GA 30322, USA
4Department of Chemistry, Purdue University, West Lafayette, IN 47907, USA

Received 8 June 2015; Accepted 11 August 2015

Academic Editor: Irene J. Virgolini

Copyright © 2015 Elizabeth De Jesus et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. A. Aliperti, J. D. Predina, A. Vachani, and S. Singhal, “Local and systemic recurrence is the achilles heel of cancer surgery,” Annals of Surgical Oncology, vol. 18, no. 3, pp. 603–607, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Singhal, S. Nie, and M. D. Wang, “Nanotechnology applications in surgical oncology,” Annual Review of Medicine, vol. 61, pp. 359–373, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. S. B. Mondal, S. Gao, N. Zhu, R. Liang, V. Gruev, and S. Achilefu, “Real-time fluorescence image-guided oncologic surgery,” Advances in Cancer Research, vol. 124, pp. 171–211, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. A. L. Vahrmeijer, M. Hutteman, J. R. van der Vorst, C. J. H. van de Velde, and J. V. Frangioni, “Image-guided cancer surgery using near-infrared fluorescence,” Nature Reviews Clinical Oncology, vol. 10, no. 9, pp. 507–518, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. G. M. van Dam, G. Themelis, L. M. A. Crane et al., “Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results,” Nature Medicine, vol. 17, no. 10, pp. 1315–1319, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Srinivasarao, C. V. Galliford, and P. S. Low, “Principles in the design of ligand-targeted cancer therapeutics and imaging agents,” Nature Reviews Drug Discovery, vol. 14, no. 3, pp. 203–219, 2015. View at Publisher · View at Google Scholar
  7. L. E. Kelemen, “The role of folate receptor α in cancer development, progression and treatment: cause, consequence or innocent bystander?” International Journal of Cancer, vol. 119, no. 2, pp. 243–250, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. P. S. Low and A. C. Antony, “Folate receptor-targeted drugs for cancer and inflammatory diseases,” Advanced Drug Delivery Reviews, vol. 56, no. 8, pp. 1055–1058, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. P. S. Low, W. A. Henne, and D. D. Doorneweerd, “Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases,” Accounts of Chemical Research, vol. 41, no. 1, pp. 120–129, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. P. S. Low and S. A. Kularatne, “Folate-targeted therapeutic and imaging agents for cancer,” Current Opinion in Chemical Biology, vol. 13, no. 3, pp. 256–262, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Lu, E. Sega, and P. S. Low, “Folate receptor-targeted immunotherapy: induction of humoral and cellular immunity against hapten-decorated cancer cells,” International Journal of Cancer, vol. 116, no. 5, pp. 710–719, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Lu, L.-C. Xu, N. Parker et al., “Preclinical pharmacokinetics, tissue distribution, and antitumor activity of a folate-hapten conjugate-targeted immunotherapy in hapten-immunized mice,” Molecular Cancer Therapeutics, vol. 5, no. 12, pp. 3258–3267, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. D. J. O'Shannessy, G. Yu, R. Smale et al., “Folate receptor alpha expression in lung cancer: diagnostic and prognostic significance,” Oncotarget, vol. 3, no. 4, pp. 414–425, 2012. View at Google Scholar · View at Scopus
  14. J. Predina, E. Eruslanov, B. Judy et al., “Changes in the local tumor microenvironment in recurrent cancers may explain the failure of vaccines after surgery,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 5, pp. E415–E424, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. K.-Y. Lin, F. G. Guarnieri, K. F. Staveley-O'Carroll et al., “Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen,” Cancer Research, vol. 56, no. 1, pp. 21–26, 1996. View at Google Scholar · View at Scopus
  16. H. Eagle, “Propagation in a fluid medium of a human epidermoid carcinoma, strain KB,” Proceedings of the Society for Experimental Biology and Medicine, vol. 89, no. 3, pp. 362–364, 1955. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Lu and P. S. Low, “Folate-mediated delivery of macromolecular anticancer therapeutic agents,” Advanced Drug Delivery Reviews, vol. 54, no. 5, pp. 675–693, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. OT. Okusanya, B. Madajewski, E. Segal et al., “Small portable interchangeable imager of fluorescence for fluorescence guided surgery and research,” Technology in Cancer Research & Treatment, vol. 14, no. 2, pp. 213–220, 2015. View at Publisher · View at Google Scholar
  19. B. F. Judy, L. A. Aliperti, J. D. Predina et al., “Vascular endothelial-targeted therapy combined with cytotoxic chemotherapy induces inflammatory intratumoral infiltrates and inhibits tumor relapses after surgery,” Neoplasia, vol. 14, no. 4, pp. 352–359, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. L. I. Laifer, K. M. O'Brien, M. L. Stetz, G. R. Gindi, T. J. Garrand, and L. I. Deckelbaum, “Biochemical basis for the difference between normal and atherosclerotic arterial fluorescence,” Circulation, vol. 80, no. 6, pp. 1893–1901, 1989. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Seok, H. S. Warren, A. G. Cuenca et al., “Genomic responses in mouse models poorly mimic human inflammatory diseases,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 9, pp. 3507–3512, 2013. View at Publisher · View at Google Scholar
  22. M. O. Lasaro and H. C. J. Ertl, “Targeting inhibitory pathways in cancer immunotherapy,” Current Opinion in Immunology, vol. 22, no. 3, pp. 385–390, 2010. View at Publisher · View at Google Scholar · View at Scopus